Endometriosis: “2025 objective” for reimbursement of a saliva test, announces Catherine Vautrin. A “promising” and “innovative” project, it must be tested on 3000 women before being marketed at €1000.
A communication campaign will be launched in France “in the coming weeks”, it was specified. One of the main associations of endometiosis patients, ENDOmind, was “ delighted by the desire to be able to benefit French women from this French innovation”